Latest Herceptin Stories

LONDON (Reuters) - Women diagnosed with early stage breast cancer are to be tested to see if they are suitable for treatment with the drug Herceptin, made by Switzerland's Roche Holding AG, Britain said on Wednesday. The move could mean that the lives of 1,000 women a year in England could be saved -- the same number saved by the national breast screening program, the Department of Health (DOH) said. Recent research has shown Herceptin can help patients with early stage breast cancer...

NEW YORK (Reuters Health) - The combination of the anti-cancer drugs Herceptin and Taxotere appears to work better than Taxotere alone in women with advanced breast cancer that has spread beyond the breast, research shows. Moreover, there is little added toxicity when Herceptin is given. Herceptin (trastuzumab) is a monoclonal antibody, meaning that it binds to one specific protein, HER2, which helps regulate cell growth. Overexpression of HER2, a sign of more aggressive cancer, occurs in...